<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6801518B-C8E0-47A7-B97F-836705903CA0"><gtr:id>6801518B-C8E0-47A7-B97F-836705903CA0</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Caldecott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600776"><gtr:id>E7BF0EA9-9761-413D-85A4-B018136F6E2A</gtr:id><gtr:title>Molecular Characterisation of Single-Strand Break Repair and Related Responses and their Role in Neuroprotection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600776</gtr:grantReference><gtr:abstractText>DNA breakage can lead to gene damage, cancer, and cell death, if not repaired rapidly and accurately. The commonest type of damage arising in cells is the single-strand break; a breakage of one of the two strands that comprise the DNA double helix. Recently, we have identified a direct link between an individual?s ability to repair single-strand breaks and hereditary neurodegenerative disease. These diseases are termed spinocerebellar ataxia with axonal neuropathy-1 (SCAN1) and ataxia oculomotor apraxia-1 (AOA1) and harbour mutations in the DNA repair genes Tdp1 and APTX, respectively. SCAN1 and AOA1 are associated with the progressive degeneration of specific parts of the brain (particularly the cerebellum), resulting ultimately in an inability of affected individuals to walk properly or to control normal movement. In this programme of work we will advance and extend our understanding of the single-strand break repair process, and address directly the relationship between this process and neurological function. This work will shed light on the link between DNA damage and neurodegeneration, and will hopefully provoke novel approaches for the treatment of certain types of neurological disease.</gtr:abstractText><gtr:technicalSummary>Single-strand breaks (SSBs) arise from a variety of sources including oxidative stress and are the commonest DNA lesions arising in cells (tens of thousands per cell per day). If not repaired, SSBs can block transcription and DNA replication and lead to genetic instability and cell death. Strikingly, recent work from my laboratory has identified that two proteins associated with hereditary neurodegenerative disease are intimate components of the single-strand break repair (SSBR) machinery, and that cells from one of these diseases possess a major defect in chromosomal SSBR. We have thus recently proposed that SSBR is critical for genetic integrity and survival in neurons, and that this process is vital for normal neurological function. These observations also raise the intriguing possibility that SSBR capacity is an aetiological factor not only for pathological neurological conditions but also for normal human ageing. In the current proposal, we will identify and characterise novel polypeptide components of SSBR and related processes to advance and extend our understanding of this critical process. To achieve this we will employ a combination of genetic, biochemical/proteomic, and cellular approaches, and also implement two new techniques that we are developing. The latter will allow us to characterise, for the first time, SSBR at a site-specific chromosomal SSB (e.g. using ChIP analyses) and to dissect this process within a context of defined chromatin structure. In addition, we will test directly and unambiguously our hypothesis that SSBR is critical for normal neurological function. To achieve this, we will examine the importance of SSBR for genetic integrity and cell survival in primary neurons and for normal neurological function in vivo, using mouse model systems.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1665281</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience 2010-2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D95B47F2-C57A-480E-88CB-C48F5A99AFF8</gtr:id><gtr:impact>Each year I host and organise a work experience week in for four-six children/yr from several local schools. During the week, the children participate in a variety of different scientific experiments in several different laboratories, with the intention of illustrating what a career in science is like.

schools typically receive great feedback from the students, who seem to enjoy the experience. This year, one school has also asked me to contribute to a career &amp;quot;speed dating&amp;quot; event in Jan 2013</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>work experience 2006</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B72D6222-9FAB-4404-B979-9EB1F3F8314C</gtr:id><gtr:impact>I organise a 1 week visit for school children during which they experience a career in science.

This activity often encourages the best students to pursue a career in Science.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Outlook lecture 2009</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3853C0A1-4490-4D9F-B2CE-4675CC9B0600</gtr:id><gtr:impact>I presented a lecture to non-specialists and members of the general public, including students from local A level colleges. This is a part of the University's outlook scheme to promote science in the community. The lecture is subsequently streamed on the web and accessible to anyone.

I have had considerable interest from attendees at the college, expressing their desire to pursue a career in science and/or medicine</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>work experience 2007-2009</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C16694A7-2323-4C3B-B4B0-514494904CA8</gtr:id><gtr:impact>Each year, I organise a 1 week visit for school children during which they experience a career in science.

This activity often encourages the best students to pursue a career in Science.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>440000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant (2010 G0901606)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0901606</gtr:fundingRef><gtr:id>01A15300-1E7E-4031-9DE7-4ACCCFF7B959</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>174000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant 2008</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>5694D4AF-72AF-4AAA-8EEE-B210D4847328</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>270000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant 2011</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>8D20A234-9EB2-463A-8867-606F23C30A02</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant (2012 MR/J006750/1)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J006750/1</gtr:fundingRef><gtr:id>6E8DADC6-2714-4618-B5F6-62380E5F3832</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Fellowship</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>98A67FED-AE21-4C9C-A832-F0FD853A603E</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Input into MRC research straegy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>29CDFF28-E771-455E-9B1B-D345DEAD05E9</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E03BA1B1-2ED4-45C5-99B4-8E52D130FA6A"><gtr:id>E03BA1B1-2ED4-45C5-99B4-8E52D130FA6A</gtr:id><gtr:title>Short-patch single-strand break repair in ataxia oculomotor apraxia-1.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae09bf89d0868254137b2df4bfae8f07"><gtr:id>ae09bf89d0868254137b2df4bfae8f07</gtr:id><gtr:otherNames>Reynolds JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E15B4B4-C591-485B-9655-67BF18E16765"><gtr:id>2E15B4B4-C591-485B-9655-67BF18E16765</gtr:id><gtr:title>APLF (C2orf13) is a novel component of poly(ADP-ribose) signaling in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1FC7AD10-4DE2-44A0-AED6-CC481972B514"><gtr:id>1FC7AD10-4DE2-44A0-AED6-CC481972B514</gtr:id><gtr:title>Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9fe7ced85dfa89ce30ae06e6cca7f242"><gtr:id>9fe7ced85dfa89ce30ae06e6cca7f242</gtr:id><gtr:otherNames>Moser J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB8BA20B-3F09-49D3-8739-FDF4FF7174DF"><gtr:id>DB8BA20B-3F09-49D3-8739-FDF4FF7174DF</gtr:id><gtr:title>TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2D75D14-8EBC-467A-A93D-FBA133482FEA"><gtr:id>D2D75D14-8EBC-467A-A93D-FBA133482FEA</gtr:id><gtr:title>PARP-3 and APLF function together to accelerate nonhomologous end-joining.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04CBD36C-3B56-4B75-8364-39A3017A016D"><gtr:id>04CBD36C-3B56-4B75-8364-39A3017A016D</gtr:id><gtr:title>Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae09bf89d0868254137b2df4bfae8f07"><gtr:id>ae09bf89d0868254137b2df4bfae8f07</gtr:id><gtr:otherNames>Reynolds JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD597D5F-EE07-4AF7-925B-787F567658A8"><gtr:id>AD597D5F-EE07-4AF7-925B-787F567658A8</gtr:id><gtr:title>XRCC1 stimulates polynucleotide kinase by enhancing its damage discrimination and displacement from DNA repair intermediates.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9065b08d4a25f8c8548a6bc0bac69d24"><gtr:id>9065b08d4a25f8c8548a6bc0bac69d24</gtr:id><gtr:otherNames>Mani RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E2B9453-E966-4580-B712-72827303251A"><gtr:id>1E2B9453-E966-4580-B712-72827303251A</gtr:id><gtr:title>DNA 3'-phosphatase activity is critical for rapid global rates of single-strand break repair following oxidative stress.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ec0137267e8c769a95c7cae672f174b"><gtr:id>8ec0137267e8c769a95c7cae672f174b</gtr:id><gtr:otherNames>Breslin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A27CFB36-005B-4D74-84A8-0AAA7E413223"><gtr:id>A27CFB36-005B-4D74-84A8-0AAA7E413223</gtr:id><gtr:title>TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cffc1dcecc4c0baa2ac7d37b3dd34adf"><gtr:id>cffc1dcecc4c0baa2ac7d37b3dd34adf</gtr:id><gtr:otherNames>G?mez-Herreros F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5691328-5A89-4A4E-A371-E2E4AF8868B8"><gtr:id>C5691328-5A89-4A4E-A371-E2E4AF8868B8</gtr:id><gtr:title>Single-strand break repair and genetic disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/df98d3748be077b8e6cd59725a036bdb"><gtr:id>df98d3748be077b8e6cd59725a036bdb</gtr:id><gtr:otherNames>Caldecott KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69115EDF-BDDD-4EBD-8B5D-0F3B285115E1"><gtr:id>69115EDF-BDDD-4EBD-8B5D-0F3B285115E1</gtr:id><gtr:title>Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62a5a9ca8ed453c8ceadb68f9e3e99fb"><gtr:id>62a5a9ca8ed453c8ceadb68f9e3e99fb</gtr:id><gtr:otherNames>El-Khamisy SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFFBFA0E-5969-459C-B81D-D09C3E619B8C"><gtr:id>EFFBFA0E-5969-459C-B81D-D09C3E619B8C</gtr:id><gtr:title>Defective DNA ligation during short-patch single-strand break repair in ataxia oculomotor apraxia 1.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae09bf89d0868254137b2df4bfae8f07"><gtr:id>ae09bf89d0868254137b2df4bfae8f07</gtr:id><gtr:otherNames>Reynolds JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16B4A0F0-BC6E-4397-8285-CD6B31AAFB0E"><gtr:id>16B4A0F0-BC6E-4397-8285-CD6B31AAFB0E</gtr:id><gtr:title>The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e42d567be93558e30e4dfe746a91cbb"><gtr:id>1e42d567be93558e30e4dfe746a91cbb</gtr:id><gtr:otherNames>Lee Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D961EE1A-039C-4EFE-A8A3-B63165304D7F"><gtr:id>D961EE1A-039C-4EFE-A8A3-B63165304D7F</gtr:id><gtr:title>A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7b7a8f49066d9d4de3c7eaacf0ad7ff8"><gtr:id>7b7a8f49066d9d4de3c7eaacf0ad7ff8</gtr:id><gtr:otherNames>Cortes Ledesma F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C901D7CF-D17D-49DA-9B7F-AC1B9F2C3A35"><gtr:id>C901D7CF-D17D-49DA-9B7F-AC1B9F2C3A35</gtr:id><gtr:title>Mutations in PNKP cause microcephaly, seizures and defects in DNA repair.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11792d8e57ee799267adfbebcc11e298"><gtr:id>11792d8e57ee799267adfbebcc11e298</gtr:id><gtr:otherNames>Shen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40FA9332-6289-4CC3-BEF6-A705443B9577"><gtr:id>40FA9332-6289-4CC3-BEF6-A705443B9577</gtr:id><gtr:title>Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/926c9864e09b8e61406466bc7a0c9ed2"><gtr:id>926c9864e09b8e61406466bc7a0c9ed2</gtr:id><gtr:otherNames>Fisher AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EAB0EC51-DF9B-4E95-AC76-FCFCD37BAF7F"><gtr:id>EAB0EC51-DF9B-4E95-AC76-FCFCD37BAF7F</gtr:id><gtr:title>Claspin promotes normal replication fork rates in human cells.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfc3c17eefa37f23cdea0fae07ca773b"><gtr:id>dfc3c17eefa37f23cdea0fae07ca773b</gtr:id><gtr:otherNames>Petermann E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CDA7334-16EF-4AF1-9585-341A193E8227"><gtr:id>5CDA7334-16EF-4AF1-9585-341A193E8227</gtr:id><gtr:title>Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a89ce910cdb4a4be994d690dc29c19b"><gtr:id>0a89ce910cdb4a4be994d690dc29c19b</gtr:id><gtr:otherNames>Dungey FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600776</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>